BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS)
$0 None (None%)
Analysed BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) News Sources
Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight
09-02-2026
yahoo.com
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
05-08-2026
yahoo.com
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18-08-2026
yahoo.com
Basilea Pharmaceutica Ltd (XSWX:BSLN) (H1 2026) Earnings Call Highlights: Revenue Surges 14% ...
18-08-2026
yahoo.com
Basilea Pharmaceutica (SWX:BSLN) Lifts Guidance Following Strong Half Year Results, Is It Fully Valued?
21-08-2026
yahoo.com
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
14-09-2026
yahoo.com
What is the current price of BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS)?
The current price of BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) is $0.
BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) since the previous trading day is $None.
BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS)?
The most recent average sentiment score for BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS)?
The most recent sentiment for BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS) is .
SEC-8K** Filing Available For BASILEA PHARMACEUTICA-REG (BPMUF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.